Boronic acid derivatives
Accela Chembio Inc 4-pentylphenylboronic Acid | 25g | 121219-12-3 | MFCD00995151 | 97+% | Shelf Life: 1080 Days | Light Sensitive
4-pentylphenylboronic Acid | 25g | 121219-12-3 | MFCD00995151 | 97+% | Shelf Life: 1080 Days | Light Sensitive
eMolecules 72824-04-5 | Allylboronic acid, pinacol cyclic ester | Synthonix - Stock | MFCD00013347 | 168.040 | C9H17BO2 | 95.000 | CC1(C)OB(CC=C)OC1(C)C | 5g | 459632954
Allylboronic acid, pinacol cyclic ester | Synthonix - Stock | 72824-04-5 | MFCD00013347 | 168.040 | C9H17BO2 | 95.000 | CC1(C)OB(CC=C)OC1(C)C | 5g | 459632954
Chemscene ChemScene | 2,3-Dichlorophenylboronic acid | 25G | CS-D1007 | 0.98 | 151169-74-3| MFCD01075703 | 190.82
ChemScene | 2,3-Dichlorophenylboronic acid | 25G | CS-D1007 | 0.98 | 151169-74-3| MFCD01075703 | 190.82
eMolecules (2-methoxyphenyl)boronic acid | ChemBridge - BBMFCD00236047 | 151.960 | C7H9BO3 | 95.000 | COc1ccccc1B(O)O | 1g | 337751488
(2-methoxyphenyl)boronic acid | ChemBridge - BBMFCD00236047 | 151.960 | C7H9BO3 | 95.000 | COc1ccccc1B(O)O | 1g | 337751488
eMolecules 411235-57-9 | Cyclopropylboronic acid | Apollo Scientific US - Building Blocks | MFCD04038750 | 85.900 | C3H7BO2 | 98.000 | OB(O)C1CC1 | 25g | 398000680
Cyclopropylboronic acid | Apollo Scientific US - Building Blocks | 411235-57-9 | MFCD04038750 | 85.900 | C3H7BO2 | 98.000 | OB(O)C1CC1 | 25g | 398000680
eMolecules 72824-04-5 | Allylboronic acid pinacol ester,98%(stabilized with Phenothiazine) | ChemScene | MFCD00013347 | 168.040 | C9H17BO2 | 98.000 | CC1(C)OB(CC=C)OC1(C)C | 100g | 536841433
Allylboronic acid pinacol ester,98%(stabilized with Phenothiazine) | ChemScene | 72824-04-5 | MFCD00013347 | 168.040 | C9H17BO2 | 98.000 | CC1(C)OB(CC=C)OC1(C)C | 100g | 536841433
Apexbio Technology LLC Pemetrexed disodium hemipenta hydrate 357166-30-4 200mg
Pemetrexed disodium hemipenta hydrate (CAS 357166-30-4) is a multitargeted antifolate that inhibits key enzymes in folate metabolism including thymidylate synthase (TS) dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFT) with Ki values for its pentaglutamate form of 1 3 nM 7 2 nM and 65 nM respectively Compared to the monoglutamate form the pentaglutamate exhibits enhanced inhibitory potency particularly against TS and GARFT Pemetrexed is approved for the treatment of advanced non-squamous non-small cell lung cancer In preclinical models it additionally modulates renal uptake of radiolabeled folates These features support its utilization in studies of folate pathway inhibition and cancer therapy
eMolecules 380430-52-4 | 3-Benzyloxycarbonylphenylboronic acid | Combi-Blocks | MFCD02179445 | 256.060 | C14H13BO4 | 98.000 | OB(O)c1cccc(c1)C(=O)OCc1ccccc1 | 1g | 117520482
3-Benzyloxycarbonylphenylboronic acid | Combi-Blocks | 380430-52-4 | MFCD02179445 | 256.060 | C14H13BO4 | 98.000 | OB(O)c1cccc(c1)C(=O)OCc1ccccc1 | 1g | 117520482
eMolecules 214360-73-3 | 4-Aminophenylboronic acid, pinacol ester | Synthonix - Stock | MFCD02093721 | 219.090 | C12H18BNO2 | 98.000 | CC1(C)OB(OC1(C)C)c1ccc(N)cc1 | 5g | 525905268
4-Aminophenylboronic acid, pinacol ester | Synthonix - Stock | 214360-73-3 | MFCD02093721 | 219.090 | C12H18BNO2 | 98.000 | CC1(C)OB(OC1(C)C)c1ccc(N)cc1 | 5g | 525905268
Medchemexpress LLC Cyclopropylboronic acid | 411235-57-9 | 99.22% | C3H7BO2 | 10 G
Cyclopropylboronic acid is an intermediate used in the synthesis of EGFR kinase inhibitor (Compound 25). This compound exhibits antiproliferative effects on EGFR mutant (EGFR Δ19del/T790M/C797S) cells. It is also applicable in lung cancer research.
- Used to synthesize EGFR kinase inhibitor
- Supports lung cancer research
- Exhibits antiproliferative effects on EGFR mutant cells
- For research use only
eMolecules 99769-19-4 | 3-Methoxycarbonylphenylboronic acid | Combi-Blocks | MFCD02093046 | 179.970 | C8H9BO4 | 98.000 | COC(=O)c1cccc(c1)B(O)O | 5g | 117520475
3-Methoxycarbonylphenylboronic acid | Combi-Blocks | 99769-19-4 | MFCD02093046 | 179.970 | C8H9BO4 | 98.000 | COC(=O)c1cccc(c1)B(O)O | 5g | 117520475